Researcher
Christophe Van De Wiele
- Disciplines:Diagnostics, Medicinal products, Laboratory medicine
Affiliations
- Department of Diagnostic Sciences (Department)
Member
From1 Oct 2018 → Today - Department of Radiology and nuclear medicine (Department)
Member
From1 Jan 2009 → 30 Sep 2018 - Department of Radiation oncology and experimental cancer research (Department)
Member
From1 Oct 2003 → 31 Dec 2008
Projects
1 - 1 of 1
- The development of 68-gallium-NOTA-somatropin, a targeted radiopharmaceutical for the diagnosis of growth hormone receptor-positive cancers.From1 Nov 2020 → TodayFunding: FWO Strategic Basic Research Grant
Publications
1 - 10 of 31
- Apoptosis imaging in oncology by means of positron emission tomography : a review(2021)
Authors: Christophe Van De Wiele, Sezgin Ustmert, Bart De Spiegeleer, Pieter-Jan De Jonghe, Mike Sathekge, Maes Alex
- Blood-brain barrier transport kinetics of NOTA-modified proteins : the somatropin case(2020)
Authors: Nathalie Bracke, Yorick Janssens, Evelien Wynendaele, Liesa Tack, Alex Maes, Christophe Van De Wiele, Mike Sathekge, Bart De Spiegeleer
Pages: 105 - 114 - PSMA-targeting positron emission agents for imaging solid tumors other than non-prostate carcinoma : a systematic review(2019)
Authors: Christophe Van De Wiele, Mike Sathekge, Bart De Spiegeleer, Pieter-Jan De Jonghe, Laurence Beels, Alex Maes
- Biodistribution and dosimetry of 195mPt-cisplatin in normal volunteers : imaging agent for single photon emission computed tomography(2013)
Authors: Machaba Michael Sathekge, J Wagener, SV Smith, N Soni, B Marjanovic-Painter, C Zinn, Christophe Van De Wiele, Yves D'Asseler, G Perkins, JR Zeevaart
Pages: 222 - 227 - 99mTechnetium-HYNIC(tricine/TPPTS)-aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model(2011)
Authors: Hildo JK Ananias, ZiLin Yu, Rudi Dierckx, Christophe Van De Wiele, Wijnand Helfrich, Fan Wang, YongJun Tan, XiaoYuan Chen, Igle J de Jong, Philip H Elsinga
Pages: 1165 - 1173 - An evaluation of FDG-PET as a predictor of metabolic response to chemotherapy in metastatic colorectal cancer patients (mCRC)(2011)Volume: 29
Authors: Nancy Van Damme, Sylvie De Bruyne, Jeroen Mertens, Christophe Van De Wiele, Wim Ceelen, Peter Smeets, Liesbeth Ferdinande, Stéphanie Laurent, Karen Geboes, Marc Peeters
Number of pages: 1 - Expression and prognostic value of glucose transporters and hexokinases in tonsil and mobile tongue squamous cell carcinoma(2011)
Authors: Philippe Deron, Hubert Vermeersch, Gilles Mees, Christel Vangestel, Patrick Pauwels, Christophe Van De Wiele
Pages: 1165 - 1172 - In vivo imaging of apoptosis in oncology : an update(2011)
Authors: Christel Vangestel, Marc Peeters, Gilles Mees, Ruth Oltenfreiter, Hendrikus H Boersma, Philip H Elsinga, Chris Reutelingsperger, Nancy Van Damme, Bart De Spiegeleer, Christophe Van De Wiele
Pages: 340 - 358 - Evaluation of glucose uptake by skeletal muscle tissue and subcutaneous fat in HIV-infected patients with and without lipodystrophy using FDG-PET(2010)
Authors: Mike Sathekge, Alex Maes, Mbo Kgomo, Anton Stoltz, Alfred Ankrah, Christophe Van De Wiele
Pages: 311 - 314 - SPECT imaging of apoptotic tumor response in a colorectal tumor model(2010)Volume: 73
Authors: Christel Vangestel, Nancy Van Damme, Gilles Mees, Steven Staelens, Christophe Van De Wiele, Marc Peeters
Number of pages: 1
Patents
1 - 1 of 1